This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA

Anurag Khetan, PhD
Executive Director, Global Upstream and Cell Line Development, Biologics Development at Bristol-Myers Squibb


Anurag Khetan heads the Early Biologics Process Development department of Bristol-Myers Squibb based in NJ. His team interfaces with Discovery and carries out process development of biologics and viral gene therapy programs ranging from molecular biology, cell line development, upstream and downstream development, and associated process analytics. Anurag has a PhD in Biochemical Engineering from the Hu group at the University of Minnesota. Anurag has had sustained contributions over nearly two decades in the industry ranging from early and late process development, post-approval development, manufacturing support, and GMP manufacturing at Merck, Biogen, Boehringer Ingelheim and BMS.

Agenda Sessions

  • KEYNOTE: Enabling Speed to Clinic for Monoclonal Antibody Programs Using a Pool of Clones for IND-Enabling Toxicity Studies